Study of the Effect of Water Soluble Oral Contrast (Gastrografin) on Postoperative Ileus After Colorectal Surgery
- Conditions
- Postoperative Ileus
- Interventions
- Drug: physiological serum
- Registration Number
- NCT01440712
- Lead Sponsor
- Hospital Universitari de Bellvitge
- Brief Summary
The purpose of this trial is to determine whether the water-soluble contrast (gastrografin) is more effective in the treatment of postoperative ileus than the conventional one.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 58
-
All patients with postoperative ileus after colorectal surgery, defined as the presence from the third postoperative day, abdominal distension, nausea, vomiting with or without abdominal pain or discomfort by dilation of bowel loops, confirmed radiology of the abdomen, and which are: Age > 18 years Patients undergoing laparotomy or laparoscopy for the following variants of colorectal disease with or without stoma:
- Neoplasia.
- Inflammatory disease.
- Diverticular disease. Patients who have been treated with standard PCA as postoperative analgesia. Signed informed consent. Undergoing elective or scheduled
-
Patient's refusal to sign informed consent
-
Pregnancy or lactation
-
Hypersensitivity to iodinated contrast agents (it´s the only contraindication to oral Gastrografin) Presence of other problems that justify the etiology of postoperative ileus:
- Anastomotic leakages.
- Mesenteric vascular disease.
- Incarcerated hernias.
- Intra-abdominal abscesses or collections.
- Metabolic or electrolyte disturbances. If during the course of the study one of the reasons previously cited as the etiology of postoperative ileus is present, the patient shall also be excluded. Also excluded patients undergoing emergency surgery.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description physiological serum physiological serum Patients included in this group will be treated with 100 ml of physiological serum 0,9% by the nasogastric tube, only once, after the diagnosis of postoperative ileus. Gastrografin Gastrografin Patients located in this group will be treated with the administration of 100 ml of gastrografin by the nasogastric tube, only once, after the diagnosis of postoperative ileus.
- Primary Outcome Measures
Name Time Method Time to resolution of postoperative ileus after surgery defined as time to tolerance of oral intake of solid or semisolid food While the patient is admitted to the hospital. An average of 11 days since the intervention.
- Secondary Outcome Measures
Name Time Method Presence of postoperative pain and analgesic required While the patient is admitted to the hospital. An average of 11 days since the intervention Postoperative complications were assessed in the intervening period between the immediate postoperative phase and when the patient is discharged
Percentage of mortality during hospitalization. While the patient is admitted to the hospital. An average of 11 days since the intervention Postoperative complications were assessed in the intervening period between the immediate postoperative phase and when the patient is discharged
Hospital stay after diagnosis of ileus While the patient is admitted to the hospital. An average of 11 days since the intervention. Postoperative complications were assessed in the intervening period between the immediate postoperative phase and when the patient is discharged.
Percentage of patients requiring total parenteral nutrition. While the patient is admitted to the hospital. An average of 11 days since the intervention Postoperative complications were assessed in the intervening period between the immediate postoperative phase and when the patient is discharged